Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hefei
Clinical trial register · China

Clinical Trials in Hefei, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Hefei 58 Fuyang 5 Wuhan 3 Wuhu 2 Bengbu 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Anhui Provincial Hospital58 Merck Sharp & Dohme LLC36 Anhui Medical University29 AstraZeneca26 Eli Lilly and Company25 Clear sponsor filter
Site location
Hefei58 Fuyang5 Wuhan3 Wuhu2 Bengbu2
All 19 locations
Target enrolment
to

Trials with a site in Hefei

58 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Anhui Provincial Hospital
Phase 2
59
Hefei
2027-08-01
Not yet open
Sacituzumab Tirumotecan Plus Toripalimab for Advanced Penile Cancer After Platinum Chemotherapy
NCT07907861Penile Squamous Cell Carcinoma (PSCC), Advanced Penile Cancer, Metastatic Penile Cancer, Locally Advanced Penile Cancer
DrugsSacituzumab tirumotecan·Toripalimab
Anhui Provincial Hospital
Phase 2
31
Hefei
2027-01-01
Not yet open
Anhui Provincial Hospital
Phase 2
35
Hefei
2026-10-01
Recruiting
Anhui Provincial Hospital
Phase 2
60
Hefei
2026-09-16
Not yet open
Anhui Provincial Hospital
Observational
580
Hefei
2026-09
Recruiting
China Metastatic Liver Cancer Clinical Registry Cohort Database
NCT07602504Liver Metastases, Metastases to Liver, Liver Cancer, Neoplasms
Anhui Provincial Hospital
Observational
2,000
Bengbu, Hefei, Qingdao
2026-06-01
Not yet open
Anhui Provincial Hospital
Phase 4
160
Hefei
2026-04-10
Not yet open
Simultaneous Vs Staged VPS and CP :A Multi-cnter RCT.
NCT07462676Ventriculoperitoneal Shunt (VPS), Cranioplasty
Anhui Provincial Hospital
Not applicable
300
Hefei
2026-04-01
Recruiting
Anti CD19 Gene Therapy for B-cell Lymphoma
NCT07211048B-cell Lymphoma
Anhui Provincial Hospital
Not applicable
18
Hefei
2026-03-20
Recruiting
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
NCT07150624Hepatocellular Carcinoma (HCC), Liver Diseases
Anhui Provincial Hospital
Phase 4
96
Hefei
2025-11-10
Recruiting
Anhui Provincial Hospital
Observational
100
Hefei
2025-10-09
Recruiting
Anhui Provincial Hospital
Phase 1
20
Hefei
2025-09-01
Not yet open
Anhui Provincial Hospital
Observational
50
Hefei
2025-09-01
Recruiting
Anhui Provincial Hospital
Early Phase 1
36
Hefei
2025-08-29
Recruiting
Anhui Provincial Hospital
Not applicable
18
Hefei
2025-08-25
Not yet open
Anhui Provincial Hospital
Phase 1
23
Hefei
2025-08-01
Recruiting
Anhui Provincial Hospital
Early Phase 1
30
Hefei
2025-07-31
Recruiting
Anhui Provincial Hospital
Not applicable
18
Hefei
2025-07-20
Recruiting
Anhui Provincial Hospital
Phase 2
97
Hefei
2025-07-14
Recruiting
Anhui Provincial Hospital
Phase 3
134
Hefei
2025-07-11
Recruiting
Anhui Provincial Hospital
Phase 2
37
Hefei
2025-07-01
Recruiting
Anhui Provincial Hospital
Early Phase 1
36
Hefei
2025-06-23
Recruiting
Anhui Provincial Hospital
Observational
600
Hefei, Suzhou, Ningbo
2025-06-01
Recruiting
Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma
NCT06961669Lymphoblastic Leukemia, Relapsed or Refractory Multiple Myeloma (RRMM)
Anhui Provincial Hospital
Not applicable
18
Hefei
2025-04-16
Recruiting
Efficacy and Safety of AK104 Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer
NCT06542549Advanced Ovarian Cancer, AK104(PD-1/CTLA-4 Bispecial Antibody), Chemotherapy, Efficacy
DrugCadonilimab
Anhui Provincial Hospital
Phase 3
100
Hefei
2025-03-11
Recruiting
Anhui Provincial Hospital
Observational
10,000
Anqing, Bengbu, Bozhou, Chizhou, Chuzhou, Fuyang, Hefei, Huaibei
2025-01-01
Recruiting
Anhui Provincial Hospital
Observational
70
Hefei
2025-01-01
Recruiting
Anhui Provincial Hospital
Early Phase 1
30
Hefei
2024-12-19
Recruiting
Anhui Provincial Hospital
Observational
600
Hefei, Wuhu
2024-12-01
Recruiting
Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT
NCT06693791Platelet Recovery After Umbilical Cord Blood Transplantation
DrugIpilimumab
Anhui Provincial Hospital
Phase 2
34
Hefei
2024-12-01
Recruiting
Anhui Provincial Hospital
Phase 1
12
Hefei
2024-11-29
Recruiting
Anhui Provincial Hospital
Phase 2
60
Fuyang, Hefei
2024-11-16
Recruiting
Anhui Provincial Hospital
Phase 2
60
Fuyang, Hefei
2024-11-10
Recruiting
Anhui Provincial Hospital
Observational
150
Hefei
2024-10-08
Recruiting
Anhui Provincial Hospital
Observational
318
Hefei
2024-08-15
Recruiting
Anhui Provincial Hospital
Phase 2
45
Fuyang, Hefei
2024-07-20
Not yet open
Anhui Provincial Hospital
Phase 2
39
Hefei
2024-07-01
Recruiting
Anhui Provincial Hospital
Phase 1/2
45
Hefei
2024-07-01
Recruiting
Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
NCT06449937Metastatic Colorectal Carcinoma, Multi-organ Metastatic Colorectal Cancer, Metastatic Malignant Neoplasm in the Liver
Anhui Provincial Hospital
Not applicable
130
Chuzhou, Fuyang, Hefei, Ma’anshan, Wuhu
2024-07
By invitation
Anhui Provincial Hospital
Phase 1
9
Hefei
2024-06-21
Active, closed
Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer
NCT06527001Progression-Free Survival, Overall Survival, Nutrition Aspect of Cancer
Anhui Provincial Hospital
Observational
300
Hefei
2024-06-16
Recruiting
Anhui Provincial Hospital
Not applicable
450
Hefei
2024-05-28
Not yet open
Anhui Provincial Hospital
Phase 1
9
Hefei
2024-05-06
Recruiting
Anhui Provincial Hospital
Phase 2
30
Hefei
2024-05-01
Recruiting
Cervical Cancer Susceptible Population Classification
NCT06405945Cervical Cancer Susceptible Population Classification
Anhui Provincial Hospital
Observational
10,000
Hefei
2024-05-01
Recruiting
Anhui Provincial Hospital
Early Phase 1
9
Hefei, Wuhan
2024-03-15
Recruiting
Anhui Provincial Hospital
Phase 3
198
Hefei, Beijing, Zhengzhou, Wuhan, Shanghai, Hangzhou
2024-03-15
Recruiting
Anhui Provincial Hospital
Observational
25
Hefei
2024-03-01
Active, closed
Anhui Provincial Hospital
Phase 3
198
Hefei, Beijing, Zhengzhou, Wuhan, Shanghai, Hangzhou
2024-03-01
Recruiting
Anhui Provincial Hospital
Not applicable
12
Hefei
2024-02-10
Recruiting
Anhui Provincial Hospital
Not applicable
70
Hefei
2024-01-01
Recruiting
An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy
NCT06151028Gynecological Malignancies, Menopausal Symptoms, Bone Loss
Anhui Provincial Hospital
Observational
490
Hefei
2023-12-01
Active, closed
Observational, Bivariate Analysis of Clinical Big Data in Patients With Cervical Cancer
NCT06480617Progression-free Survival Was Defined From Date of Surgery to Disease Progression Post-surgery or Death or Last Follow-up, Overall Survival Was Defined as Time From Surgery to Death From Any Cause or Last Follow-up
Anhui Provincial Hospital
Observational
3,000
Hefei
2023-10-31
Recruiting
Anhui Provincial Hospital
Phase 1/2
70
Hefei
2023-09-01
Recruiting
Anhui Provincial Hospital
Observational
70
Hefei
2023-07-01
Recruiting
Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease
NCT05823376Platelet Recovery After Umbilical Cord Blood Transplantation
DrugAvatrombopag
Anhui Provincial Hospital
Observational
40
Hefei
2023-05-04
Recruiting
Anhui Provincial Hospital
Observational
467
Hefei
2019-01-01
Recruiting
Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation
NCT07830576Colorectal Liver Metastases, Colorectal Neoplasms, Liver Neoplasms
Anhui Provincial Hospital
Observational
205
Hefei
2017-02-01
Rows per page Showing 1–58 of 58
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/hefei

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 58 of those studies with a site in Hefei that also match the filters currently applied.

How many clinical trials are recruiting in Hefei?

44 of the 58 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 10 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hefei), 58 studies
PhaseStudiesRecruitingShare
Observational191532.8%
Phase 212820.7%
Not applicable9815.5%
Early Phase 1558.6%
Phase 1528.6%
Phase 3436.9%
Phase 1/2223.4%
Phase 4213.4%

Most active sponsors

Lead sponsors with the most studies (Hefei)
Lead sponsorStudiesRecruiting
Anhui Provincial Hospital5844
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.